• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks

    Study Finds Red Wine Stops Lung Cancer Cells

    Written by Vivien Diniz
    |
    Mar. 05, 2014 11:44AM PST

    A recent study by Brock and McMaster University scientists shows that red wine, consumed in moderation, inhibits the spread of lung cancer cells.

    A recent study by Brock and McMaster University scientists shows that red wine, consumed in moderation, inhibits the spread of lung cancer cells. However, it’s far too early for physicians to start prescribing Pinot Noir to patients.

    According to an article by The Star:

    […]the findings just published in the scientific journal Cancer Cell International did have a positive bouquet. Thestudy found that moderate amounts of red wine inhibit the spread of lung cancer cells.

    The study concludes:

    Our data suggest that wine may have considerable anti-tumour and chemoprevention properties in lung cancer and deserves further systematic investigation in animal models of lung cancer.

    Click here to view the full report.

     

     

    The Conversation (0)

    Go Deeper

    AI Powered
    Life Science Outlook: World Edition

    Life Science Outlook: World Edition

    Novocure's Optune Lua® Receives Approval in Japan for the Treatment of Unresectable Advanced/Recurrent Non-Small Cell Lung Cancer

    Novocure's Optune Lua® Receives Approval in Japan for the Treatment of Unresectable Advanced/Recurrent Non-Small Cell Lung Cancer

    Latest News

    Appendix 4C Cashflow Statementand Quarterly Activities Report

    Lexaria Celebrates its 70th Patent Award

    More News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Life Science Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES